欧诺宁通过通过E2F2抑制DNA损伤反应来使乳头甲状腺癌细胞对西斯普拉丁敏感
Xian Deng1,2,3, Xin Qian1, Lian Cheng1
1Department of General Surgery (Thyroid Surgery), The Affiliated Hospital, Southwest Medical University, Luzhou, China, swmu.edu.cn.
International journal of endocrinology
|February 16, 2026
概括
欧诺宁通过抑制DNA损伤修复,增强了对乳头甲状腺癌 (PTC) 的西斯普拉丁疗效. 这种天然化合物向E2F2/MDC1通路,为克服PTC中的化学抵抗提供了潜在的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 乳头甲状腺癌 (PTC) 通常会对化疗产生耐药性,从而限制治疗的疗效.
- 一种天然异黄的欧诺宁显示出抗瘤潜力,但其在PTC化学抵抗中的作用尚未被探索.
研究的目的:
- 在PTC中调查欧诺宁对西斯普拉丁敏感性的影响.
- 阐明奥诺宁作用背后的分子机制,重点关注DNA损伤反应 (DDR).
主要方法:
- 利用了PTC细胞系,并评估了欧诺宁和西斯普拉丁对细胞增殖,殖民地形成和上皮细胞-介质细胞过渡的作用.
- 研究了DNA损伤反应 (DDR) 和同源重组 (HR) 修复途径.
- 分析了E2F2和MDC1.1的表达.
主要成果:
- 奥诺宁抑制了PTC细胞的增殖和上皮细胞-介质细胞过渡.
- 奥诺宁的预治疗显著降低了西斯的IC50,提高了它的疗效.
- 欧诺宁降低了E2F2的调节,随后减少了MDC1的表达,并损害了DNA修复能力.
结论:
- 奥诺宁通过E2F2/MDC1轴减弱DDR,使PTC细胞对西斯普拉丁敏感.
- 奥诺宁是一种潜在的辅助疗法,用于克服PTC中西斯普拉丁耐药性.
相关概念视频
DNA Damage Can Stall the Cell Cycle
3.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.2K
DNA Damage can Stall the Cell Cycle
10.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.2K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Inhibition of Cdk Activity
6.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Negative Regulator Molecules
38.6K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K


